Nitrates

Key Points

• Nitrates relieve angina by vasodilation that improves myocardial oxygen supply-demand balance.
• Nitroglycerin is used for acute angina relief and prophylaxis before exertional triggers.
• Typical stable-angina discomfort is exertional chest/neck/jaw/shoulder/arm pressure that improves with rest or sublingual nitroglycerin within about 5 minutes.
• Sublingual nitroglycerin may be repeated every 5 minutes up to 3 doses while reassessing symptoms and blood pressure.
• If symptoms are not improved after the first dose or worsen, call 911 immediately.
• Persistent chest pain after a full 3-dose nitrate sequence (5-minute spacing) is treated as high-risk ACS and requires emergent escalation.
• Concurrent use with sildenafil or similar PDE-5 inhibitors can cause severe hypotension and is contraindicated.
• Store sublingual tablets in the original airtight glass container and protect from heat/light.
• Transdermal nitrate systems require a daily nitrate-free interval (commonly about 10-12 hours) to reduce tolerance.
• Older adults have higher postural-hypotension and fall risk during nitrate therapy and need deliberate position-change teaching.
• Chronic nitrate therapy requires close blood-pressure monitoring because orthostatic hypotension can complicate treatment.
• IV nitroprusside is high-risk therapy that requires close titration and toxicity surveillance.

Pathophysiology

Angina reflects myocardial hypoxia from reduced coronary perfusion and/or increased oxygen demand. Nitrates relax vascular smooth muscle, especially venous capacitance vessels and coronary vessels, reducing preload and myocardial workload while improving perfusion.

Nitrates are one antianginal option; beta-blockers and calcium channel blockers may also be used to reduce oxygen demand.

Classification

• Angina context (triage): Stable angina is usually predictable; unstable angina is an emergency pattern; variant (Prinzmetal) angina is vasospasm-related; microvascular angina reflects small-vessel ischemic pathways.
• Sublingual nitroglycerin: Rapid PRN rescue for acute stable-angina episodes.
• Extended-release oral forms: Ongoing antianginal prevention pathways.
• Topical/transdermal forms: Paste or patch for sustained symptom prevention.
• Intravenous nitrates: Higher-acuity monitored settings.

Nursing Assessment

NCLEX Focus

Prioritize symptom response and hemodynamic safety after each dose, with immediate emergency escalation when pain does not improve promptly.

• Assess chest-pain characteristics, baseline blood pressure, heart rate, and perfusion before administration.
• Reassess chest pain and blood pressure after each sublingual dose.
• Screen for absolute interaction risk with recent PDE-5 inhibitor use (for example sildenafil-class agents within about 24 hours).
• Assess contraindication patterns including severe anemia, increased intracranial pressure, hypersensitivity, right ventricular infarction history, hypertrophic cardiomyopathy, and circulatory failure.
• In pregnancy or breastfeeding, use nitrate therapy only with specialist-directed risk-benefit review.
• Distinguish predictable exertional episodes from rest/unpredictable chest pain patterns that suggest unstable angina and require emergency escalation.
• Identify clients at higher hypotension risk (older adults, low baseline systolic pressure, autonomic dysregulation, or long-term diuretic therapy) and plan intensified monitoring.

Nursing Interventions

• For sublingual administration, place tablet under tongue and allow it to dissolve; do not chew or crush.
• Keep client seated during sublingual dosing because hypotension/dizziness can occur.
• Avoid eating or smoking during sublingual administration because absorption can be altered.
• Dose pattern: one sublingual tablet every 5 minutes, maximum three tablets in 15 minutes unless protocol/order differs.
• Call 911 if symptoms are not improved after the first dose, worsen, or persist after the full initial series.
• In high-suspicion MI pathways, document chest-pain onset time and escalate rapidly because chapter guidance targets urgent angioplasty/reperfusion timing (about a 90-minute window).
• Teach prophylactic use about 5-10 minutes before activities known to trigger exertional angina.
• For transdermal paste/patch forms, apply to clean dry upper-body/arm skin, rotate sites to reduce skin irritation, and schedule a nitrate-free interval (commonly 10-12 hours/day) to reduce tolerance.
• If a caregiver applies topical nitrate paste or patch, use gloves to reduce accidental transdermal absorption and secondary hypotension risk.
• Do not use nitrate patches for acute chest-pain rescue.
• Hold and clarify administration if systolic blood pressure is below about 90 mm Hg or heart rate is above about 100 beats/min unless alternate prescriber parameters are provided.
• If symptomatic hypotension occurs, place the client supine with legs elevated and notify the care team promptly.
• Counsel clients to avoid alcohol and tobacco exposure patterns that can worsen nitrate-related hemodynamic instability.
• Store sublingual tablets in original airtight glass container and protect from heat/light exposure.

PDE-5 Inhibitor Interaction

Do not administer nitrates with sildenafil-class medications due to risk of life-threatening hypotension.

Nitroprusside High-Acuity Risk

Nitroprusside can cause precipitous hypotension and dose-related cyanide toxicity; use only with continuous monitoring and shortest feasible high-dose exposure.

Pharmacology

Drug/Class	Typical Clinical Use	Key RN Considerations
Nitroglycerin (sublingual)	Acute stable-angina episode relief	1 dose every 5 minutes up to 3 doses, BP check after each dose, seated dosing, 911 escalation if not improved after first dose/worsening
Nitroglycerin (prophylactic use)	Pre-exertional angina prevention	Administer before trigger activity (about 5-10 minutes), reinforce carry-and-storage safety
Nitroglycerin paste/patch	Sustained antianginal prevention	Apply to clean dry skin, rotate sites, and include a daily nitrate-free interval (about 10-12 hours)
Nitroprusside (IV)	Hypertensive emergency and acute pulmonary-edema/hemodynamic-control pathways	Continuous monitored infusion only, frequent BP titration, and cyanide-toxicity surveillance
Antianginal combination strategy	Nitrate + beta-blocker or calcium channel blocker plans	Nitrates are first-line for stable angina; adjunct blockers are selected to reduce ischemic-event risk and improve symptom control

Clinical Judgment Application

Clinical Scenario

A client with known stable angina reports chest pain at rest and receives the first sublingual nitroglycerin dose.

• Recognize Cues: Active chest pain plus nitrate exposure risk for hypotension.
• Analyze Cues: Immediate priority is determining early response and whether emergency escalation is needed.
• Prioritize Hypotheses: Persistent pain after first dose may represent unstable ischemia requiring emergency care.
• Generate Solutions: Reassess pain and BP promptly, prepare repeat dose if indicated, and activate EMS per protocol threshold.
• Take Action: Keep client seated, administer per timing rules, and call 911 without delay if no early improvement/worsening.
• Evaluate Outcomes: Pain and hemodynamics stabilize or emergency pathway is activated rapidly.

Related Concepts

• coronary-artery-disease - Nitrates are core antianginal therapy in CAD symptom pathways.
• calcium-channel-blockers - Alternative/add-on antianginal class.
• beta-blockers - Additional myocardial oxygen-demand reduction strategy.
• phosphodiesterase-5-inhibitors - Absolute interaction concern due to severe hypotension risk.

Self-Check

1. What reassessment is required after each sublingual nitroglycerin dose?
2. When should emergency help be activated during a nitrate rescue sequence?
3. Why must nitrate storage and administration technique teaching be explicit?